Impact of Prolonging CMV Prophylaxis in High-Risk (CMV D plus /R-) Lung Transplant Recipients

被引：0
|
作者：
Herrera, S. [1 ]
Khan, B. [2 ]
Husain, S. [1 ]
Binnie, M. [2 ]
Chow, C. [2 ]
Martinu, T. [2 ]
Chaparro, C. [2 ]
Keshavjee, S. [2 ]
Singer, L. G. [2 ]
Tikkanen, J. [2 ]
机构：
[1] Univ Hlth Network, Div Infect Dis, Multi Organ Transplant Unit, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.282
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
272
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] Impact of Prolonging CMV Prophylaxis in High Risk (CMV D plus /R-) Lung Transplant Recipients
    Khan, B.
    Husain, S.
    Binnie, M.
    Chow, C.
    Martinu, T.
    Chaparro, C.
    Keshavjee, S.
    Singer, L. G.
    Tikkanen, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S319 - S319
  • [2] Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients
    Humar, A
    Mazzulli, T
    Moussa, G
    Razonable, RR
    Paya, CV
    Pescovitz, MD
    Covington, E
    Alecock, E
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1065 - 1070
  • [3] Impact of Extended CMV Prophylaxis on CMV Infection in Lung Transplant Recipients
    Dorey-Steins, Z.
    Varghese, P.
    Patel, M.
    Marron, R.
    Myers, C. N.
    Mills, N.
    Chowdhury, J. M.
    Priest, S.
    Zhao, H.
    Brown, J. C.
    Mulhall, P.
    Galli, J.
    Shenoy, K. V.
    Cordova, F. C.
    Criner, G. J.
    Mamary, A. J.
    Sehgal, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir
    Palmer, SM
    Grinnan, DC
    Reams, BD
    Steele, MP
    Messier, RH
    Davis, RD
    [J]. CLINICAL TRANSPLANTATION, 2004, 18 (02) : 179 - 185
  • [5] CMV prophylaxis in high-risk renal transplant patients (D+/R-) by acyclovir with or without hyperimmune (CMV) immunoglobulins: A prospective study
    Rostaing, L
    Martinet, O
    Cisterne, JM
    Icart, J
    Chabannier, MH
    Durand, D
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (06) : 489 - 494
  • [6] Incidence and Characteristics of CMV Infection in High Risk (D plus R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis
    Bhattarai, M.
    Puttarajappa, C.
    Mour, G.
    Wu, C.
    Sood, P.
    Shah, N.
    Mehta, R.
    Tevar, A.
    Hariharan, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [7] Impact of extended CMV prophylaxis in adult renal transplant recipients at high risk for CMV infection
    Stuckey, Linda J.
    Park, Jeong M.
    Luan, Fu L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 565 - 565
  • [8] The problem of cytomegalovirus (CMV) prophylaxis in high-risk renal transplant recipients
    Maiwald, J
    Sperschneider, H
    Stein, G
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (09) : 1897 - 1897
  • [9] Ganciclovir prophylaxis in CMV high-risk renal transplant recipients.
    Kletzmayr, J
    Safar, T
    Kovarik, J
    Klauser, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3210 - A3210
  • [10] Effect of Prophylaxis Duration on the Incidence of CMV Viremia and Hospitalization Rates in D plus /R- Kidney Transplant Recipients
    Sia, J.
    Westervelt, J.
    Lyden, E.
    Miles, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 211 - 212
12345